Pharmacists are integral to oncology care, optimizing treatment plans, managing adverse effects, and supporting precision medicine through collaborative practice agreements.

Soft tissue sarcomas (STS) are rare malignant tumors arising from connective tissues such as muscle, fat, and blood vessels, ...

Sophia Humphreys, PharmD, MHA, BCBBS, discusses common barriers to cancer therapy and how care teams can assist patients in ...

New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...

Up to 4 million people may lose coverage, increasing uninsured rates, especially in non-Medicaid expansion states and among ...

Lisa Taylor-Swanson, PhD, explains how including Indigenous and Hispanic women in conversations around menopause care helps fine-tune interventions. How do clinicians balance evidence-based practices ...

Marcus Flores, PharmD, BCPS, BCOP, discusses the vital role of pharmacists in multidisciplinary cancer care, exploring ...

Individuals in Michigan with low incomes and health problems were more likely to have employment gains when they were covered with Medicaid, which could have implications when work requirements change ...

Testosterone therapy lacks evidence for preventing muscle loss, bone fractures, heart disease, or cognitive decline in women.

A machine learning model using basic clinical data can predict PH risk, identifying key predictors like low hemoglobin and elevated NT-proBNP. Researchers have developed a machine learning model that ...

Panelists discuss how: LDL-C control remains a national crisis, with many patients not on therapy or failing to reach target ...

MOG-IgG positivity is rare in MS patients, complicating diagnosis and treatment, especially in Asian populations with lower ...